Karakasis, P.; Patoulias, D.; Giannakoulas, G.; Sagris, M.; Theofilis, P.; Fragakis, N.; Biondi-Zoccai, G.
Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis. J. Clin. Med. 2024, 13, 6411.
https://doi.org/10.3390/jcm13216411
AMA Style
Karakasis P, Patoulias D, Giannakoulas G, Sagris M, Theofilis P, Fragakis N, Biondi-Zoccai G.
Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis. Journal of Clinical Medicine. 2024; 13(21):6411.
https://doi.org/10.3390/jcm13216411
Chicago/Turabian Style
Karakasis, Paschalis, Dimitrios Patoulias, George Giannakoulas, Marios Sagris, Panagiotis Theofilis, Nikolaos Fragakis, and Giuseppe Biondi-Zoccai.
2024. "Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis" Journal of Clinical Medicine 13, no. 21: 6411.
https://doi.org/10.3390/jcm13216411
APA Style
Karakasis, P., Patoulias, D., Giannakoulas, G., Sagris, M., Theofilis, P., Fragakis, N., & Biondi-Zoccai, G.
(2024). Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis. Journal of Clinical Medicine, 13(21), 6411.
https://doi.org/10.3390/jcm13216411
